Pascual-Lucas M, Lacosta AM, Montanes M, Canudas J, et al. Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Abeta40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study. Alzheimers Dement 2025;21:e70776.
PMID: 41058018